Cutaneous Safety Profile of Nemolizumab in Moderate‑to‑Severe Atopic Dermatitis and Prurigo Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2) Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2). J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 2];10(2):s748. Available from: https://skin.dermsquared.com/skin/article/view/4121